Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion
- PMID: 17726274
Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion
Abstract
Purpose: Previous studies suggest that progesterone (PROG) has a substantial protective effect against several types of brain injury. Since most cases of human stroke are caused by permanent occlusion of cerebral arteries, we assessed the neuroprotective effects of PROG on cerebral infarction and behavioral deficits in a permanent MCAO (pMCAO) model.
Methods: pMCAO was produced by surgical insertion of a silicone-coated nylon filament into the right internal carotid artery. Laser-Doppler flowmetry was used to monitor cerebral blood flow for 10 min post-occlusion. PROG (8 mg/kg) or vehicle (2-hydroxypropyl-beta-cyclodextrin) was administered intraperitoneally at 1 h post-occlusion followed by subcutaneous injections at 6, 24 and 48 h post-occlusion. Measurements of infarct volumes (cortical, subcortical and total) were performed at 72 h and functional recovery, assessed by rotarod test, were performed 24, 48, and 72 h after pMCAO.
Results: Following PROG treatment, stained sections revealed a significant reduction in cortical, caudate-putamen and hemispheric infarct volumes (% contralateral structure) compared to vehicle-injected controls. In addition, PROG treatment reduced functional deficits on the accelerating rotarod apparatus.
Conclusion: We demonstrated and confirmed the neuroprotective effect of PROG using a permanent model of focal brain ischemia in rats.
Similar articles
-
Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.Ann Emerg Med. 2006 Apr;47(4):381-9. doi: 10.1016/j.annemergmed.2005.12.011. Epub 2006 Feb 21. Ann Emerg Med. 2006. PMID: 16546625
-
Neuroprotective effects of progesterone following stroke in aged rats.Behav Brain Res. 2010 May 1;209(1):119-22. doi: 10.1016/j.bbr.2010.01.026. Epub 2010 Jan 28. Behav Brain Res. 2010. PMID: 20109497
-
SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25. Exp Neurol. 2008. PMID: 18462720
-
Neuroprotection by pravastatin in acute ischemic stroke in rats.Brain Res Rev. 2008 Jun;58(1):48-56. doi: 10.1016/j.brainresrev.2007.10.010. Epub 2007 Nov 1. Brain Res Rev. 2008. PMID: 18035423 Review.
-
Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia - an initial screening study.Metab Brain Dis. 1997 Sep;12(3):237-49. Metab Brain Dis. 1997. PMID: 9346472 Review.
Cited by
-
Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection.Neuropharmacology. 2013 Apr;67:78-87. doi: 10.1016/j.neuropharm.2012.10.004. Epub 2012 Nov 12. Neuropharmacology. 2013. PMID: 23154302 Free PMC article.
-
Progesterone's Effects on Cognitive Performance of Male Mice Are Independent of Progestin Receptors but Relate to Increases in GABAA Activity in the Hippocampus and Cortex.Front Endocrinol (Lausanne). 2021 Jan 11;11:552805. doi: 10.3389/fendo.2020.552805. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33505354 Free PMC article.
-
Neuroprotective actions of neurosteroids.Front Endocrinol (Lausanne). 2011 Oct 11;2:50. doi: 10.3389/fendo.2011.00050. eCollection 2011. Front Endocrinol (Lausanne). 2011. PMID: 22649375 Free PMC article.
-
Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats.Brain Res. 2009 Feb 27;1257:94-101. doi: 10.1016/j.brainres.2008.12.048. Epub 2008 Dec 29. Brain Res. 2009. PMID: 19135987 Free PMC article.
-
Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway.Neuroscience. 2012 May 17;210:442-50. doi: 10.1016/j.neuroscience.2012.03.008. Epub 2012 Mar 16. Neuroscience. 2012. PMID: 22450229 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources